Founder and CEO Interviewed for Transcriptomics Article in January 15, 2003 Issue of Genetic Engineering News

During an interview with writer Gail Dutton, Founder and CEO, Dr. Christopher Savoie described how GNI’s transcriptome-based approach for elucidating gene relationships decreases drug discovery and development time dramatically by bridging the gap between genomics and proteomics. The article appeared in the January 15^th, 2003 issue of Genetic Engineering News, the first (introduced in 1981) and now the most widely read biotechnology publication worldwide.